Provided by Tiger Trade Technology Pte. Ltd.

BioNexus Gene Lab Corp.

1.55
-0.0400-2.52%
Volume:730
Turnover:1.12K
Market Cap:4.55M
PE:-1.24
High:1.55
Open:1.52
Low:1.52
Close:1.59
52wk High:6.10
52wk Low:1.07
Shares:2.93M
Float Shares:1.88M
Volume Ratio:0.03
T/O Rate:0.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2467
EPS(LYR):-1.6075
ROE:-33.66%
ROA:-18.99%
PB:0.58
PE(LYR):-0.96

Loading ...

Oct 16, 2023

Major Issues Report

Form 8-K - Current report
Oct 11, 2023

Major Issues Report

Form 8-K - Current report
Sep 07, 2023

Major Issues Report

Form 8-K - Current report
Aug 16, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 24, 2023

Major Issues Report

Form 8-K - Current report
Jul 20, 2023

Major Issues Report

Form 8-K - Current report
Jul 17, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jul 05, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
May 09, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2023

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Mar 31, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2023

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 15, 2022

Major Issues Report

8-K - Current report
Aug 15, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 16, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 06, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 09, 2020

[Rev.]Quaterly Report

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
Nov 03, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 08, 2020

Major Issues Report

8-K - Current report